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Background: The practice of using medical service claims in epidemiologic research on hypertension is becoming
increasingly common, and several published studies have attempted to validate the diagnostic data contained
therein. However, very few of those studies have had the benefit of using actual measured blood pressure as the
gold standard. The goal of this study is to assess the validity of claims data in identifying hypertension cases and
thereby clarify the benefits and limitations of using those data in studies of chronic disease etiology.
Methods: Disease status was assigned to 19,150 employees at a U.S. manufacturing company where regular
physical examinations are performed. We compared the presence of hypertension in the occupational medical
charts against diagnoses obtained from administrative claims data.
Results: After adjusting for potential confounders, those with measured blood pressure indicating stage 1
hypertension were 3.69 times more likely to have a claim than normotensives (95% CI: 3.12, 4.38) and those
indicating stage 2 hypertension were 7.70 times more likely to have a claim than normotensives (95% CI: 6.36, 9.35).
Comparing measured blood pressure values identified in the medical charts to the algorithms for diagnosis of
hypertension from the claims data yielded sensitivity values of 43-61% and specificity values of 86–94%.
Conclusions: The medical service claims data were found to be highly specific, while sensitivity values varied by
claims algorithm suggesting the possibility of under-ascertainment. Our analysis further demonstrates that such
under-ascertainment is strongly skewed toward those cases that would be considered clinically borderline or mild.
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Healthcare claims data play a vital role in research aimed
at crafting health policy, establishing medical standards
of care, and understanding disease etiology. While the
ideal methods of collecting clinical data for epidemiolo-
gic research are medical chart review and physical exam-
ination [1], these more direct approaches are laborious
and expensive, and thus the use of administrative data-
sets is becoming increasingly common. Most often
derived in the United States from Medicare, Medicaid,
and Veterans Administrative populations, these datasets
are used extensively in health services research and* Correspondence: baylah.tessier@yale.edu
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distribution, and reproduction in any mediumpharmacoepidemiology, but are increasingly of interest
for etiologic studies [2].
Several studies have evaluated the use of claims data
in accurately identifying cases of hypertension [1,3-9],
though very few have used serial blood pressure mea-
surements abstracted from chart data as the source of
comparison. Instead, research has focused on using self-
reported hypertension as a reference standard for asses-
sing the accuracy of claims data and chart review data
[5,6,9-11]. However, the use of self-report data presents
significant limitations in any estimates of the sensitivity
and specificity of other data sources. Lack of medical
knowledge, medical terminology as well the tendency for
those with hypertension to underreport all contribute to a
significant skepticism about self-reported data as a validat-
ing data source [9,12]. Additional issues arising in the
literature include: the impact of differential health andd Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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tions of physician notes for diagnostic purposes [13]; and
exclusive attention to cases in evaluating the accuracy of
patient claims [4].
With the vast majority of healthcare dollars being
spent on chronic conditions, it is essential for research-
ers to continue to assess the benefits and limitations of
administrative datasets for the scientific study of the
causes and outcomes of chronic diseases, as well as to bet-
ter understand which strategies of disease ascertainment
are the most useful in conducting etiologic research. The
objective of this study is to assess the use of administrative
data for identifying cases of hypertension in a large indus-
trial cohort which has been under long-term scrutiny.
Using medical claims data, we examine the presence of
hypertensive disease in employees with measured blood
pressure readings from routine physical examinations at
the workplace as a job safety requirement.Methods
The study company is a multinational producer of
aluminum and related products, operating in 24 states
and around the world. The US workforce has varied
from over 50,000 to around 30,000, with the majority
of workers in hourly manufacturing jobs. Notably, al-
though workers may select from a menu of health
benefits in terms of cost, there is only a single pre-
ferred provider organization (PPO) network available
at each location; managed care organization (MCO)
alternatives are offered at a small handful of locations.
Because the offered plans are rich in terms of coverage,
the vast majority of employees and their families enroll
in them.Data sources
All data are available as part of a unique academic-
corporate partnership that began in 1997 for the purpose
of developing and implementing workplace safety and
occupational health policies for this large, multi-site
aluminum manufacturer. The research agreement allows
the investigators regularly updated company databases
which are then de-identified and linked. The databases
have been described in greater detail in previous publica-
tions [2,14]. Briefly, they include the following:Human resources
Provided annually, this database contains all employee
demographic information, including date of birth, race,
and sex. Files are created at the start of employment and
document all changes in job title, job grade, job status
(active, on leave, retired), job category (hourly or salary),
and plant location.Occupational health screening
This database provides basic health screening informa-
tion for employees who participate in fitness-for-duty
evaluations at the start of employment and medical
surveillance programs which are typically performed
every three years of employment. Although the extent of
screening an employee participates in varies by job, all
employees in this study participated in at least one med-
ical screening program in which blood pressure mea-
surements were collected. Occupational health data
were provided to the investigators in one of two ways:
some plants maintain an electronic database, to which
the investigators have access, of data gathered from
mandatory health screenings, while other plants merely
record such data in the employees' paper charts. Begin-
ning in 2002 the investigators, in an attempt to collect
more comprehensive data on employee health risk fac-
tors, began abstracting health data from the individual
plant medical departments. Data collected include smok-
ing history, cholesterol, blood pressure, height, weight,
education status, and marital status. Chart notes, such as
physician comments regarding diagnosis or history of
hypertension, are not available.
Insurance claims database
Investigators annually receive medical and pharmacy
claims from a central data processing center, which in
turn receives the data from each individual third party
administrator. Data include ICD-9 codes for disease
diagnosis [15] and National Drug Codes (NDC) for pre-
scription information [16]. Data on date of service, pro-
vider type, and provider location are also available.
These data are complete for almost all employees
enrolled in the PPO plan.
Data linkage
Databases were linked by using an encrypted unique
identifier created by the investigators to ensure human
subject privacy.
Study sample
A study set was created by first selecting all active
employees who had one or more systolic (SBP) and
diastolic (DBP) blood pressure measurements in their
occupational health screening records for the period
2003 – 2009 and were enrolled in a PPO health insurance
plan. Plants represented in this sample encompassed all
aspects of the company’s sectors, including smelting and
fabricated aluminum products, and employees were
included regardless of job.
We examined the cohort in two ways: first, actual blood
pressure measurements from the occupational health
records were categorized into four groups: normotensive
(SBP <120 and DBP <80), pre-hypertensive (SBP of 120–

















Tenure* (yrs), mean(sd) 13.6(12.2)
Average No. of Chart Measurements, mean(sd) 2.6(4.2)






*Age and tenure were calculated using the date of the employee's first blood
pressure measurement.
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140–159 or a DBP of 90–99), or stage 2 hypertensive (SBP
of ≥160 or a DBP ≥100). If an employee’s blood pressure
values overlapped between 2 groups, he was placed in the
higher group. Second, each employee was classified into
one of two categories: normal blood pressure or high
blood pressure based on the pattern of their measure-
ments in their medical charts. If an employee had at least
one high blood pressure reading, they were classified as
having high blood pressure; if they only had normal read-
ings, they were classified as having normal blood pressure.
The borderline category was omitted from this part of the
analysis to allow us to calculate sensitivity and specificity
values.
Administrative claims data (defined as a physician
billing and/or hospital admission of hypertension as the
primary diagnostic code, 401.XX-405.XX) for the study
individuals for the same time period were then examined
by defining hypertension using the following possible
algorithms: 1) at least one medical claim based on a
face-to-face examination or hospitalization or 2) at least
two separate medical claims. No time gap was required
between separate medical claims.
Statistical analysis
A Monte Carlo logistic regression was performed on all
blood pressure measurements to elucidate the predictors
of having at least one claim for hypertension while adjust-
ing for covariates. The simulation was chosen whereby a
single, randomly selected blood pressure reading was
included for ordinal logistic regression analysis. This
approach was conducted in order to account for the
varied number of repeated blood pressure measurements
per employee. Further, it allowed us to tease out the po-
tentially confounding influence of those in the borderline
category, as well as control for disease severity and other
individual covariates. The resulting adjusted odds ratio
estimate for the effect of blood pressure category on hav-
ing a hypertensive claim was recorded. This simulation
was conducted 10,000 times in order to determine the
central tendency for the odds ratio as well as the 95% con-
fidence interval.
Frequency (2×2) tables were then constructed for each
algorithm used to define employees’ hypertension status
from the administrative claims data. Sensitivity was
defined as the proportion of employees with high blood
pressure measurements in their occupational health
records that were identified as hypertensive by a claims-
based algorithm. Specificity was calculated as the pro-
portion of employees with normal blood pressure
measurements in their medical charts and not identified
by a claims-based algorithm as having hypertension. The
positive predictive value (PPV) of using claims was cal-
culated as the proportion of employees with claims forhypertension who had normal blood pressure measure-
ments in their medical charts. The negative predictive
value (NPV) of using claims was calculated as the pro-
portion of employees without a claim for hypertension
who had normal blood pressure measurements in their
medical charts.
Statistical analyses were performed with SAS version
9.2.Results
Our final cohort consisted of 19,150 employees, repre-
senting over 30 U.S. plants for the period 2003–2009.
Table 1 shows the demographics for the cohort. The
mean age for the cohort was 43.8 years, with 85.3% male
and 80.8% Caucasian. 73.7% of the cohort consisted of
hourly employees with an average company tenure of
close to 14 years. The mean number of clinic encounters
per employee where a blood pressure measurement was
recorded was 2.6, with 30% of employees having more
than 3 encounters within the study period. Figure 1











Figure 1 Classification of Blood Pressure Measurements
(n = 49,628).
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49,628 measurements, nearly half were pre-hypertensive
readings, 20% were in the normal range, 25% indicated
stage 1 hypertension, and 7% stage 2 hypertension. Less
than 1% of all the medical claims for hypertension were
in the form of hospital admissions, the vast majority
being physician visits.
Table 2 shows the results of the Monte Carlo logistic
regression model. All employees and all blood pressure
readings were included in this analysis. After controllingTable 2 Predictors of having a claim for hypertension,
Monte Carlo logistic model, n = 19,150
Parameter Level Odds ratio
Estimate L95% U95%
Blood pressure Normal 1.00 Reference
Borderline 1.92 1.63 2.26
Stage 1 3.69 3.12 4.38
Stage 2 7.70 6.36 9.35
Employee Type Salaried 0.74 0.74 0.75
Hourly 1.00 Reference
Age per year 1.08 1.08 1.08
Race Non-white 1.38 1.36 1.39
White 1.00 Reference
Sex Female 0.85 0.84 0.86
Male 1.00 Referencefor age, sex, race, and employee type, there were signifi-
cantly increased odds of having a medical claim for
hypertension as disease severity increases. Those with
blood pressure values indicating stage 1 hypertension
were 3.69 times more likely to have a claim for hyper-
tension compared to those with normal blood pressure
values (95% CI: 3.12, 4.38), and those with blood pres-
sure values indicating stage 2 hypertension were 7.70
times more likely to have a claim for hypertension com-
pared to those with normal blood pressure values (95%
CI: 6.36, 9.35).
Only employees with high or normal blood pressure
measurements were included for the sensitivity and spe-
cificity analyses. 54% (or 10,415 employees) met this cri-
terion, while 46% (8,735 ‘borderline’ employees) were
excluded. 40.6% had high blood pressure measurements
in their charts, while 13.8% were in the normal range
and 45.6% did not fit either category and were labeled as
borderline. Of those borderlines that were excluded, 72%
had only pre-hypertensive readings (defined as SBP
between 120–139 or DBP between 80–89), while the
remaining 28% had mixed normal/pre-hypertensive
readings. Males were more likely to have hypertensive
readings in their charts compared with females (p <
0.0001), and hourly employees were more likely to have
hypertensive readings in their charts compared with sal-
aried employees (p < 0.0001). Those in the high blood
pressure category had an average tenure of 15 years,
whereas those in the normal category had an average
tenure of 11 years. Likewise, the average age was 5 years
older in the hypertensive category.
As Table 3 shows, the claims data captures between
43–52% of those employees who have high blood pres-
sure readings in their occupational health records. Using
the looser algorithm of ≥1 medical claim, we calculate a
sensitivity of 52%, while using the more stringent algo-
rithm of ≥2 medical claims results in a sensitivity of
43%. Specificity ranged from 86% for employees with ≥1
medical claim to 90% for employees with ≥2 medical
claims. Table 3 also shows the results of the PPV and
NPV calculations. The PPV ranged from 92–93% and
NPV ranged from 35–38%.
In an attempt to avoid inaccurate classification of
cases due to blood pressure variability [17], weTable 3 Association between measured blood pressure
readings and claims data
Claims
algorithm








4026 51.77% 85.87% 91.52% 37.67%
≥ 2 medical
claim
3339 42.94% 90.41% 92.96% 34.97%
Tessier-Sherman et al. BMC Public Health 2013, 13:51 Page 5 of 7
http://www.biomedcentral.com/1471-2458/13/51conducted a subanalysis of our cohort using a more re-
strictive case definition. Only employees who had two or
more consistent blood pressure readings during this
period, i.e. their blood pressure measurements were per-
sistently normal or hypertensive, were included (n =
1766). For example, if employees had three readings and
only the 2nd and 3rd readings were categorized as high,
that employee was not included in the cohort. Similar to
the Monte Carlo, no time gap was required between
measurements. Table 4 shows these results. Sensitivity
for the one and two claims algorithms were 61% and
52% and specificity values were 94% and 89%, respect-
ively. Although the PPV values were comparable to
those of the larger cohort, the NPV improved signifi-
cantly, ranging from 56%–60%.Discussion
In this study, we examined the relationship between
measured blood pressure values and administrative med-
ical claims for hypertension. By first including all mea-
surements for all employees in a multivariate simulation,
we found the odds of having a claim of hypertension
were significantly increased for those employees with ac-
tual blood pressure reading suggesting stage 1 hyperten-
sion as compared to those with normal measurements,
and increased even more dramatically for those with
readings suggesting stage 2 hypertension. This model
allowed us to control for several potentially confounding
variables such as an unequal number of repeated mea-
sures per employee, age, sex, employee type and race.
We next assessed the accuracy of two algorithms for
defining hypertension using claims data compared to ac-
tual blood pressure measurements from occupational
health records. Our results show a sensitivity of 42–52%
and a specificity of 86–90% depending on the algorithm
used. These results are comparable to other studies util-
izing different methods including self-reported survey
data on hypertension and review of medical records to
validate claims data. These studies have reported sensi-
tivity values ranging from 52–75% and specificity values
ranging from 75–94% [1,4,7-10,13].
In a study of claims-based algorithms for identifying
chronic medical conditions, Rector et al. reported aTable 4 Association between measured blood pressure
readings and claims data for subanalysis cohort
Claims
algorithm








654 61.29% 88.70% 89.22% 60.02%
≥ 2 medical
claim
555 52.01% 93.56% 92.50% 56.09%sensitivity and specificity of 52% and 91% respectively in
diagnosing hypertension using a combination of one
medical claim and one pharmacy claim when compared
with self-reported surveys [9]. Tu et al. also reported
sensitivity of 73% and specificity of 95% utilizing two
outpatient claims for detecting hypertension compared
with physician-assigned diagnosis [10]. The sensitivity
and specificity dropped to 64% and 94% respectively,
when the same combination (2 outpatient claims for
detecting hypertension) was compared to self-reported
survey data.
In our claims dataset, the more sensitive algorithm
was to use at least one medical claim for identifying dis-
ease; changing the algorithm to at least two medical
claims decreased the sensitivity and only modestly
increased the specificity. We initially conducted this ana-
lysis using all employees who had at least one high blood
pressure measurement as the source of comparison;
however, we repeated the analysis using a more stringent
case definition of classifying employees who had two or
more consistent readings during this period. The study
population dropped from 10,415 in the initial analysis to
1766 in the subanalysis. Although the specificity values
did not significantly change, sensitivity values improved.
All analyses were conducted regardless of whether or
not the employee was using prescription medication for
lowering blood pressure, an obvious reason for a false
positive. Because these medications are commonly used
for conditions not associated with high blood pressure,
removing those employees from the analysis would have
limited impact. Indeed in a sensitivity analysis where we
eliminated normotensives on blood pressure lowering
medications, our results did not change substantively for
the ≥1 and ≥2 medical claim algorithms: sensitivity
values remained unchanged, specificity values increased
to 95.51% and 98.44%, positive predictive values
increased to 97.55% and 98.96%, and negative predictive
values decreased modestly to 36.41% and 33.38%, re-
spectively. With nearly 70% of false positives using blood
pressure lowering medications, the specificity rates
reflected in this study are likely lower than previously
found because of this phenomenon.
This study has certain limitations. First, although we
are confident from our multivariate model that sex, race
and employee type are unlikely to be the source of sig-
nificant confounding, we are less confident about job
type, as only certain jobs require regular examinations
which in turn might lead to referral for treatment, while
other jobs have no such “screening”. Second, by choos-
ing a cross-sectional study design, we were able to take
advantage of a large and robust dataset that includes a
varied number (sometimes only one) of intermittent
blood pressure readings per person. However, by allow-
ing for the inclusion of all individuals with at least one
Tessier-Sherman et al. BMC Public Health 2013, 13:51 Page 6 of 7
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examine the data in a temporal manner. Specifically,
those who entered the cohort later in the study period
have shorter windows of opportunity for having a claim
in the administrative dataset. This likely contributed to
conservative estimates. The third limitation was the
unbalanced nature of the data. In particular, not all
employees had the same number of blood pressure mea-
surements. The Monte Carlo simulation mitigated the
problem of increased probability of a hypertensive read-
ing with increased measurements. Lastly, inherent in the
use of claims data is the potential for missing claims due
to physician preference in choosing a diagnostic code for
patients with comorbidities. In this study, the frequency
of hypertension claims suggests that such a bias is not
likely leading to an underestimation of disease.
Conclusions
This study not only provides evidence of the potential
value of using administrative claims in epidemiologic re-
search on hypertension, but also demonstrates that the
inevitable under-ascertainment from using claims data
to study hypertension is not at random. Those most
likely to be missed through the use of claims driven ana-
lyses are those with the least severe disease. Conversely,
specificity appears to be lost in large measure because of
treatment. One of the major strengths of this study was
the use of actual blood pressure measurements from
employee health records as the comparison data source.
This is likely superior to self-reported survey data for
verification of hypertension and is more comparable to
using physician diagnosis of hypertension abstracted
from medical records as the gold standard.
While the wide availability of administrative health
datasets provides researchers with boundless opportun-
ities for analyzing data, analyzing subsets of claims data,
as was done in this study, should allow investigators to
more thoroughly understand the strengths and limita-
tions of using claims datasets for etiologic research in
hypertension. Although our high specificity values
demonstrates the value of using claims data in defining a
cohort of hypertensives, using the claims data to identify
cases of hypertension as a covariate in statistical models
may introduce under-ascertainment. Mitigating this,
however, our analysis strongly suggests that such under-
ascertainment is skewed toward those cases that would
be considered clinically borderline or mild.
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